Pro- and Anti-Inflammatory Cytokine Balance in Major Depression: Effect of Sertraline Therapy
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The specific associations between antidepressant treatment and alterations in the levels of cytokines remain to be elucidated. In this study, we aimed to explore the role of IL-2, IL-4, IL-12, TNF-α, TGF-β1, and MCP-1 in major depression and to investigate the effects of sertraline therapy. Cytokine and chemokine levels were measured at the time of admission and 8 weeks after sertraline treatment. Our results suggest that the proinflammatory cytokines (IL-2, IL-12, and TNF-α) and MCP-1 were significantly higher, whereas anti-inflammatory cytokines IL-4 and TGF-β1 were significantly lower in patients with major depression than those of healthy controls. It seems likely that the sertraline therapy might have exerted immunomodulatory effects through a decrease in the proinflammatory cytokine IL-12 and an increase in the anti-inflammatory cytokines IL-4 and TGF-β1. In conclusion, our results indicate that Th1-, Th2-, and Th3-type cytokines are altered in the depressed patients and some of them might have been corrected by sertraline treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fluoxetine, paroxetine, venlafaxine, and sertraline have been shown to have the potential to increase the levels of TGF-β1, which may contribute to their antidepressant effects. 391 , 392”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [392]
Experimental — accuracy not yet measuredIn the citing paper
“Sutcigil et al. found elevated serum levels of IL-12, which decreased after eight weeks of sertraline therapy [120].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [120]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delves, P. J., & Roitt, I. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430107 · Cited by 1,666
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1189 · Cited by 364
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
Cited by
Items 201–300 of 323
Rigobon, A. V., Kanagasabai, T., & Taylor, V. H. (2018) · BMC Obesity · doi:10.1186/s40608-018-0208-2 · Cited by 28
Roumelioti, M., Steel, J. L., Yabes, J. G., Vowles, K. E., Vodovotz, Y., Beach, S. R., Rollman, B. L., Weisbord, S. D., Unruh, M. L., & Jhamb, M. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.09.002 · Cited by 24
Allison, D. J., Sharma, B., & Timmons, B. W. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.05.006 · Cited by 25
Neurochemical and behavioral responses to inflammatory immune stressors
Anisman, H. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s26 · Cited by 22
Mileva, G. R., Rooke, J., Ismail, N., & Bielajew, C. H. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.004 · Cited by 24
The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol
dos Santos, A. H., Vila-Verde, C., Guimarães, F. S., Joca, S. R. L., & Lisboa, S. F. D. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411101217 · Cited by 23
Jahangard, L., & Behzad, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577250 · Cited by 22
Achour, M., Salem, I. B., Ferdousi, F., Nouira, M., Fredj, M. B., Mtiraoui, A., Isoda, H., & Saguem, S. (2021) · Journal of the American Nutrition Association · doi:10.1080/07315724.2021.1873871 · Cited by 20
Park, H. J., Kim, S. K., Kang, W. S., Woo, J., & Kim, J.-W. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2013-0224 · Cited by 20
Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
McCallum, R. T., & Perreault, M. L. (2021) · Cells · doi:10.3390/cells10092270 · Cited by 21
Tang, Q., Qu, M., Gao, Y., Li, X., Zhao, R., Xu, H. W., Li, J., & Mao, Y. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s83964 · Cited by 21
Podlipný, J., Hess, Z., Vrzalová, J., Rosolová, H., Beran, J., & Petrlová, B. (2010) · Physiological Research · doi:10.33549/physiolres.931695 · Cited by 20
Sohan, M., Qusar, M. S., Shahriar, M., Islam, S. M. A., Bhuiyan, M. A., & Islam, M. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288159 · Cited by 18
MCP-1 and CCR2 gene polymorphisms in Parkinson’s disease in a Han Chinese cohort
Gao, L., Tang, H., Nie, K., Wang, L., Zhao, J., Gan, R., Huang, J., Feng, S., Zhu, R., Duan, Z., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1990-3 · Cited by 18
Lapsley, C. R., Irwin, R. E., McLafferty, M., Thursby, S. J., O’Neill, S. M., Bjourson, A. J., Walsh, C. P., & Murray, E. K. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00877-7 · Cited by 18
Gao, X., Li, Y., Sun, Z., Xu, H., Ma, G., Deng, Q., Zhang, C. X., & Li, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02313-0 · Cited by 22
Holbrook, E. M., Zambrano, C. A., Wright, C. T. O., Dubé, E. M., Stewart, J. R., Sanders, W. J., Frank, M. G., MacDonald, A. S., Reber, S. O., & Lowry, C. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065176 · Cited by 19
The Association between Gut Microbiota and Depression in the Japanese Population
Yang, Y., Mori, M., Wai, K. M., Jiang, T., Sugimura, Y., Munakata, W., Mikami, T., Murashita, K., Nakaji, S., & Ihara, K. (2023) · Microorganisms · doi:10.3390/microorganisms11092286 · Cited by 17
Type 2 diabetes and mental disorders; a plausible link with inflammation
Hajebrahimi, B., Kiamanesh, A. R., Farid, A. A. A., & Asadikaram, G. (2016) · Cellular and Molecular Biology · doi:10.14715/cmb/2016.62.13.13 · Cited by 18
Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment
Edberg, D., Hoppensteadt, D., Walborn, A., Fareed, J., Sinacore, J. M., & Halaris, A. E. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.06.010 · Cited by 18
Nahar, Z., Sal‐Sabil, N., Sohan, M., Qusar, M. S., & Islam, M. R. (2022) · Health Science Reports · doi:10.1002/hsr2.1005 · Cited by 20
Jovanovic, A. M., Mitkovic-Voncina, M., Kostic, M., Jeremic, M., Todorovic, J., Popadic, D., Tosevski, D. L., & Markovic, I. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113987 · Cited by 16
The complicated relationship between inflammation and metabolic dysfunction
Abtin, S., Ziveh, T., & Rezaee-Tavirani, M. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01729-y · Cited by 15
The core inflammatory factors in patients with major depressive disorder: a network analysis
Zeng, Y., Sun, B., Zhang, F., Hu, Z., Li, W., Lan, X., Ning, Y., & Zhou, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1216583 · Cited by 17
Yin, M., Heng, Z., Li, J., Wang, L., Zhu, M., Wang, N., Yang, P., & Yang, Z. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.02.062 · Cited by 15
Sertraline and Citalopram Actions on Gut Barrier Function
Eyzaguirre‐Velásquez, J., González-Toro, M. P., González‐Arancibia, C., Escobar-Luna, J., Beltrán, C. J., Bravo, J. A., & Julio‐Pieper, M. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06702-8 · Cited by 15
Białek, K. I., Czarny, P. L., Wigner, P., Synowiec, E., Barszczewska-Pietraszek, G., Bijak, M., Szemraj, J., Niemczyk, M., Tota-Glowczyk, K., Papp, M., et al. (2021) · Genes · doi:10.3390/genes12050667 · Cited by 14
Ramon‐Duaso, C., Rodríguez-Morató, J., Selma-Soriano, E., Fernández-Avilés, C., Artero, R. D., de la Torre, R., Pozo, Ó. J., & Robledo, P. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108030 · Cited by 14
Fernandes, B. M., Siqueira, C. C., Vieira, R. M., Moreno, R. A., & Soeiro‐de‐Souza, M. G. (2022) · Mental health and physical activity · doi:10.1016/j.mhpa.2022.100442 · Cited by 14
Wu, X., Gu, J., Zou, Z., Yu, M., Zhang, C., Xiao, Q., Chen, X., & Li, C. (2022) · Brain Sciences · doi:10.3390/brainsci12101376 · Cited by 13
The hygiene hypothesis and affective and anxiety disorders
Rook, G. A. W., & Lowry, C. A. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_11 · Cited by 17
Wu, Q., He, Q., Zhang, X., Chen, S., & Xue, X. (2024) · Aging and Disease · doi:10.14336/ad.2024.0834 · Cited by 17
Patel, A. N., Varma, J. R., & Ganguly, B. (2024) · Cureus · doi:10.7759/cureus.62991 · Cited by 16
Chen, H., Zhao, X., Ma, X., Ma, H., Zhou, C., Zhang, Y., Peng, Z., Xue, S., & Cai, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1388946 · Cited by 12
Victoriano, G. M., Zhu, Y., Middleton, F. A., Massa, P. T., Ajulu, K., Webster, M. J., & Weickert, C. S. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116141 · Cited by 11
Rafiee, L., Hajhashemi, V., & Javanmard, S. H. (2016) · PubMed Central · Cited by 13
Piperlongumine produces antidepressant-like effects in rats exposed to chronic unpredictable stress
Zhang, L., Liu, C., Yuan, M., Huang, C., Chen, L., Su, T., Liao, Z., & Gan, L. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000498 · Cited by 12
Neurotrophic Factors and Antidepressant Action: Recent Advances
O’Leary, O. F., & Ċastrén, E. (2010) · Modern trends in psychiatry · doi:10.1159/000319514 · Cited by 12
Proinflammatory cytokine levels in patients with conversion disorder
Tiyekli, U., Çalıyurt, O., & Tiyekli, N. D. (2012) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2012.00676.x · Cited by 11
Ardakani, M. T., Kheshti, R., & Maryam, M. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2309-y · Cited by 11
Russell, B., Hrelja, K. M., Adams, W. K., Zeeb, F. D., Taves, M. D., Kaur, S., Soma, K. K., & Winstanley, C. A. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114000 · Cited by 10
MCP-2/CCL8 Level Associated With Suicidal Ideation in Elderly Men With Major Depression
Liu, M., Tsai, S., Yeh, H., Wu, C., & Lin, C. (2020) · Archives of Suicide Research · doi:10.1080/13811118.2019.1649772 · Cited by 11
Post-Myocardial Infarction Depression
Rousseau, G., Bah, T. M., & Godbout, R. (2012) · InTech eBooks · doi:10.5772/33408 · Cited by 13
Razavi, S., Jahromi, M., Amirpour, N., & Khosravizadeh, Z. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.129367 · Cited by 10
Önal, H. T., Yetkin, D., & Ayaz, F. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578514 · Cited by 9
Linking Omega-3 Fatty Acids and Depression
Godos, J., Castellano, S., Galvano, F., & Grosso, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815238-6.00013-4 · Cited by 13
Microglia in the pathogenesis of depression, insomnia and their comorbidity
Liu, F., Guo, D., Gao, T., Diao, M., & Han, Y. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100030 · Cited by 11
Fluoxetine treatment for major depression decreases the plasma levels of cytokines
Shen, Y., Lu, P., Wei, L., Cai, L., Hu, X., & Chen, W. (2010) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb10.1097 · Cited by 7
Zhou, J., Zhou, J. L., Sun, Z., Feng, L., Zhu, X., Yang, J., & Wang, G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.593710 · Cited by 11
Impact of psychological stress on the outcomes of assisted reproduction in Tunisian infertile women
Sallem, A., Essoussi, H., Mustapha, H., Zaouali, M., & Ajina, M. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.40.250.32207 · Cited by 8
Study on anti-inflammatory and immunomodulatory effects of fluoxetine in rat models of inflammation
Kostadinov, I., Delev, D. P., Petrova, A., Stanimirova, I., Draganova, K., Kružliak, P., Kostadinova, I. I., & Murdjeva, M. (2015) · European Journal of Inflammation · doi:10.1177/1721727x15618671 · Cited by 8
Chaves, R. D. C., Mallmann, A. S. V., de Oliveira, N. F., Capibaribe, V. C. C., da Silva, D. M. A., Lopes, I. S., Valentim, J. T., Riello, G. B. C., de Carvalho, A. M. R., Fonteles, M. M. D. F., et al. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104758 · Cited by 12
Momeni, M., Ghorban, K., Dadmanesh, M., Hajebrahimi, B., Khodadadi, H., Hassanshahi, G., & Arababadi, M. K. (2014) · Clinical Laboratory · doi:10.7754/clin.lab.2013.130238 · Cited by 9
Role of Serotonergic System in Regulating Brain Tumor-Associated Neuroinflammatory Responses
Karmakar, S., & Lal, G. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_14 · Cited by 7
Antidepressant pharmacotherapy: focus on sex differences in neuroimmunopharmacological crossroads
Pitychoutis, P. M., Tsitsilonis, O., & Papadopoulou‐Daifoti, Z. (2010) · Future Neurology · doi:10.2217/fnl.10.28 · Cited by 7
Davalos-Guzman, A., Vegas-Rodriguez, F. J., Ramírez-Rodríguez, G. B., Flores‐Ramos, M., Romero-Luevano, P. V., Gonzalez-Olvera, J. J., & Saracco-Álvarez, R. A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1283406 · Cited by 7
Early Th1-Th2 cytokine imbalance as a predictor for post-stroke depression at 3 months
Zhao, H., Li, W., Xu, Q., Chen, P., & Wang, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119650 · Cited by 6
Ding, H., Wang, Y., Gao, Y., Ye, F., Yao, K., Cao, L., Liu, Z., Wang, G., & Zhang, J. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116950 · Cited by 6
Çetin, G. Y., Balkarlı, A., Öksüz, A. N., Kimyon, G., Pehlivan, Y., Orhan, F. Ö., Kısacık, B., Çobankara, V., Sayarlıoğlu, H., Onat, A. M., et al. (2014) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2014.03.022 · Cited by 6
Lin, C.-C., & Huang, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.698257 · Cited by 7
Major depressive disorder (mdd): emerging immune targets at preclinical level
Varma, M., Kaur, A., Bhandari, R., Kumar, A., & Kuhad, A. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2225216 · Cited by 6
Imunologia do transtorno bipolar
Barbosa, I. G., Huguet, R. B., Neves, F. S., Bauer, M. E., & Teixeira, A. L. (2009) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852009000100009 · Cited by 6
Zabihi, M., Hajhashemi, V., Talebi, A., & Minaiyan, M. (2017) · EXCLI journal · doi:10.17179/excli2016-727 · Cited by 9
Peters, E. M. J., Neusetzer, M., Akinci, S., Murat, A., Treuherz, S., Rose, M., Leweke, F., Leichsenring, F., Conrad, M. L., & Kruse, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.571636 · Cited by 7
TNF-α Increase in a Cohort of Depressive Patients
Groh, A., Jahn, K., Walter, M., Heck, J., Lichtinghagen, R., Janke, E., L, S. W. M., Deest, M., Frieling, H., Bleich, S., et al. (2021) · Disease Markers · doi:10.1155/2021/8897421 · Cited by 6
Nautiyal, K. D., Li, R., Yellapragada, S. V., Thiagarajan, P., Mims, M. P., & Rivero, G. (2014) · Leukemia Research Reports · doi:10.1016/j.lrr.2014.11.001 · Cited by 5
The Role of Inflammation in Depression
Trinidad, A. C. (2015) · CRC Press eBooks · doi:10.1201/b19089-3 · Cited by 5
Antidepressant-Like Effect of Bauhinia blakeana Dunn in a Neuroinflammation Model in Mice
Herrera-Ruiz, M. L., Santillan‐Urquiza, M. A., Romero‐Cerecero, O., Zamilpa, A., Jiménez‐Ferrer, E., & Tortoriello, J. (2019) · Medical Principles and Practice · doi:10.1159/000502996 · Cited by 5
Fan, V. S., & Giardino, N. D. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-673-3_7 · Cited by 5
Sertraline and inflammatory markers in major depression: a systematic review and meta-analysis
Xie, Z., Gao, Z., Li, X., Li, S., Tang, F., & Zhang, C. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00596-4 · Cited by 5
Li, J.-B., Ye, X.-B., & Tu, X. M. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i11.110699 · Cited by 4
Nakasujja, N., Vecchio, A., Saylor, D. R., Lofgren, S. M., Nakigozi, G. F., Boulware, D. R., Kisakye, A., Batte, J., Mayanja, R., Anok, A., et al. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-020-00920-6 · Cited by 7
Mumby, P. B., Adams, W., Smith, S. E., Rao, M. S., & Stiff, P. J. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.12.014 · Cited by 4
Case Report: Special recoveries from major mental illness in childhood: a case series
Monarch, E. S., & Foss, S. (2025) · Frontiers in Child and Adolescent Psychiatry · doi:10.3389/frcha.2025.1377547 · Cited by 4
Neuroinflammatory Hypothesis in Major Depressive Disorder
Varma, G. S. (2014) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.5455/cap.20130507091423 · Cited by 10
Li, A., Yellapragada, S. V., Mims, M. P., Frolov, A., & Rivero, G. (2016) · British Journal of Haematology · doi:10.1111/bjh.14031 · Cited by 4
Modulation of Inflammation by Antidepressants
Baune, B. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00031-3 · Cited by 5
Refai, A. A., Jumaa, M. I., Yousef, E. M., Aljehani, A. M., Alduraywish, R. A., Elkabary, M. R., Hanafy, S. M., Seleem, H. S., & El-Roghy, E. S. (2025) · Medicina · doi:10.3390/medicina61040751 · Cited by 4
Li, C., Wang, Y., Chen, J., Xiao, S., Lou, M., Ding, M., & Xing, Y. (2026) · BMC Psychiatry · doi:10.1186/s12888-025-07685-4 · Cited by 4
Rao, L., Verma, V., Jain, S., Pinapati, K. K., Bhagyawant, S. S., Sharma, S. K., & Srivastava, N. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01288-8 · Cited by 4
Kraneveld, A. D., & Garssen, J. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-06151-1_22 · Cited by 3
Min, G., Zhang, Y., Zhu, G., Gao, W., Kang, Y., Yu, K., & Yue, J. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06825-8 · Cited by 3
Elsayed, M., & Connor, C. J. (2018) · EMJ Dermatology · doi:10.33590/emjdermatol/10312460 · Cited by 4
Eleni, I., Theofanis, V., Zisis, B., & Stamoula, Ε. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.09.010 · Cited by 2
Trastornos afectivos y psicóticos en la esclerosis múltiple
Moyano, B. P., & Benito‐León, J. (2015) · Revista de Neurología · doi:10.33588/rn.6111.2015206 · Cited by 5
Escitalopram-Associated Recurrent Sinusitis: A Case Report
Yeşilkaya, Ü. H., & Sen, M. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001369 · Cited by 2
Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF
Çetin, G. Y., Balkarlı, A., Öksüz, A. N., Kimyon, G., Pehlivan, Y., Orhan, O., Kısacık, B., Çobankara, V., Sayarlıoğlu, H., Onat, A. M., et al. (2014) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2014.03.022 · Cited by 2
Białek, K. I., Czarny, P. L., Wigner, P., Synowiec, E., Kołodziej, Ł., Bijak, M., Szemraj, J., Papp, M., & Śliwiński, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168983 · Cited by 2
Autism Spectrum Disorders and Circulating Chemokines
Abdallah, M. W., Michel, T. M., & Kőhidai, L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_92 · Cited by 2
Inflammation-induced depression : Studying the role of proinflammatory cytokines in anhedonia
van Heesch, F. (2014) · Utrecht University Repository (Utrecht University) · Cited by 13
Altunöz, S., Dolapoğlu, N., Baykan, Ö., Bolat, H., Avcıkurt, A. S., & Karlıdere, T. (2025) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.70070 · Cited by 1
The Anti-depressive Effect of Samul-tanggahyangbuja on Chronic Mild Stress in Ovariectomized Rats
Jeong, J., Choi, C., Seo, Y.-J., Cho, H.-B., & Kim, S.-B. (2013) · The Journal of Korean Obstetrics and Gynecology · doi:10.15204/jkobgy.2013.26.4.030 · Cited by 2
INFLAMMATION AND DEPRESSION: MECHANISMS AND INVOLVED MOLECULES
Hajebrahimi, B., & Mohammad, K. A. (2013) · Cited by 2
The Effect of Samul-tanggahyangbuja on Anti-Depressive Behavior and Immunity
Jang, Y., Kim, S.-B., Choi, C.-M., Seo, Y.-J., & Cho, H.-B. (2013) · The Journal of Korean Obstetrics and Gynecology · doi:10.15204/jkobgy.2013.26.4.014 · Cited by 1
dos Santos, A. H. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-04012021-103831 · Cited by 1
Evolutionary Perspectives and Projects on Harmonisation of Private Law in EU
Feiden, S., & Schmid, C. U. (1999) · Cited by 1
Ofuchi, A. S. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2010.tde-14012011-161822 · Cited by 2
Girard, S. (2009) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/30754
Metadata
- Authors
- Sutcigil, L., Oktenli, C., Musabak, U., Bozkurt, A., Cansever, A., Uzun, O., Sanisoglu, S. Y., Yesilova, Z., Ozmenler, N., Ozsahin, A., & Sengul, A.
- Affiliations
- Gülhane Askerî Tıp Akademisi (TR)
- Venue
- Clinical and Developmental Immunology
- Publisher
- Hindawi Limited
- Published
- 2007
- Volume
- 2007
- Pages
- 1-6
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC2248234
- OpenAlex
- W1998520631
- Cited by
- 315
- References
- 36
- Citations by year
- 2026: 2 · 2025: 15 · 2024: 19 · 2023: 13 · 2022: 9 · 2021: 26 · 2020: 24 · 2019: 16 · 2018: 14 · 2017: 21 · 2016: 28 · 2015: 11 · 2014: 28 · 2013: 17 · 2012: 16
- FWCI
- 4.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- AYBU AVESIS (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Gülhane Military Medical Academy
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, sertraline, cytokines, chemokines, inflammatory cytokines, anti-inflammatory cytokines, IL-12, IL-4, TNF-α, TGF-β1, MCP-1, immunomodulation, antidepressant effects, Th1/Th2 balance
- MeSH terms
- Adult, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interleukin-2, Male, Tumor Necrosis Factor-alpha, Interleukin-4, Cytokines, Interleukin-12, Chemokine CCL2, Sertraline, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.